LIVE:NASDAQLive Ventures Incorporated Analysis
Data as of 2026-04-15 - not real-time
$13.60
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Live Ventures is trading well below its intrinsic valuation, with a price that appears dramatically discounted relative to its cash-generating capacity and book value. The company’s PE ratio is extremely low, and its price‑to‑book ratio is well under one, suggesting a strong margin of safety. However, the stock is embedded in a highly cyclical consumer sector and exhibits elevated volatility and beta, which amplify short‑term price swings. Recent corporate communication highlighted activity in its steel manufacturing arm, indicating continued focus on that segment, but the firm carries a very high debt‑to‑equity profile that could constrain financial flexibility. Operating metrics such as ROE are robust, and free cash flow remains positive, supporting the undervaluation thesis. Technical signals show the price below key moving averages and a bearish trend direction, though the MACD histogram hints at a possible near‑term bounce. Volume is trending upward, suggesting growing interest despite the risk backdrop. In summary, the fundamentals are compelling, but the risk environment is pronounced, requiring a measured approach to positioning.
Investors should weigh the deep discount and solid cash flow against the high leverage, sector cyclicality, and pronounced price volatility. The absence of a dividend eliminates income considerations, while the lack of analyst coverage adds an element of informational opacity. Given the current dynamics, a cautious but optimistic stance may be warranted for medium to long horizons, while short‑term exposure should be managed prudently.
Investors should weigh the deep discount and solid cash flow against the high leverage, sector cyclicality, and pronounced price volatility. The absence of a dividend eliminates income considerations, while the lack of analyst coverage adds an element of informational opacity. Given the current dynamics, a cautious but optimistic stance may be warranted for medium to long horizons, while short‑term exposure should be managed prudently.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish technical positioning below major moving averages
- Elevated volatility and beta increasing price risk
- Undervalued fundamentals providing downside protection
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant valuation discount relative to DCF fair value
- Strong ROE and positive free cash flow supporting earnings growth
- Recent strategic focus on steel manufacturing enhancing operational outlook
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Deep price discount offering substantial upside potential
- Robust balance sheet metrics aside from high leverage
- Resilient cash generation that can service debt and fund future growth
Key Metrics & Analysis
Financial Health
Revenue Growth-2.70%
Profit Margin5.02%
P/E Ratio2.9
ROE26.32%
ROA2.76%
Debt/Equity235.12
P/B Ratio0.4
Op. Cash Flow$29.1M
Free Cash Flow$22.4M
Technical Analysis
TrendBearish
RSI51.6
Support$10.25
Resistance$14.49
MA 20$12.88
MA 50$14.75
MA 200$15.79
MACDBullish
VolumeIncreasing
Fear & Greed Index88.64
Valuation
Fair Value$30.75
GradeUndervalued
TypeValue
Risk Assessment
Beta1.25
Volatility89.12%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.